These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12794305)

  • 1. Conserved cholecystokinin receptor transmembrane domain IV amino acids confer peptide affinity.
    Ren Y; Bläker M; Seshadri L; McBride EW; Beinborn M; Kopin AS
    J Mol Neurosci; 2003 Apr; 20(2):115-24. PubMed ID: 12794305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCK-B/Gastrin receptor transmembrane domain mutations selectively alter synthetic agonist efficacy without affecting the activity of endogenous peptides.
    Bläker M; Ren Y; Seshadri L; McBride EW; Beinborn M; Kopin AS
    Mol Pharmacol; 2000 Aug; 58(2):399-406. PubMed ID: 10908308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists.
    Bläker M; Ren Y; Gordon MC; Hsu JE; Beinborn M; Kopin AS
    Mol Pharmacol; 1998 Nov; 54(5):857-63. PubMed ID: 9804620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
    Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin.
    Kennedy K; Gigoux V; Escrieut C; Maigret B; Martinez J; Moroder L; Fréhel D; Gully D; Vaysse N; Fourmy D
    J Biol Chem; 1997 Jan; 272(5):2920-6. PubMed ID: 9006937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the extracellular domains of the cholecystokinin receptor in agonist binding.
    Silvente-Poirot S; Escrieut C; Wank SA
    Mol Pharmacol; 1998 Aug; 54(2):364-71. PubMed ID: 9687578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A segment of five amino acids in the second extracellular loop of the cholecystokinin-B receptor is essential for selectivity of the peptide agonist gastrin.
    Silvente-Poirot S; Wank SA
    J Biol Chem; 1996 Jun; 271(25):14698-706. PubMed ID: 8663021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic amino acids at the C-terminus of the third intracellular loop are required for the activation of phospholipase C by cholecystokinin-B receptors.
    Wang HL
    J Neurochem; 1997 Apr; 68(4):1728-35. PubMed ID: 9084447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the cholecystokinin-B/gastrin receptor transmembrane domains in determining affinity for subtype-selective ligands.
    Kopin AS; McBride EW; Quinn SM; Kolakowski LF; Beinborn M
    J Biol Chem; 1995 Mar; 270(10):5019-23. PubMed ID: 7890609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CCK-B/gastrin receptor splice variants in human peripheral blood mononuclear cells.
    Schmitz F; Schrader H; Otte J; Schmitz H; Stüber E; Herzig K; Schmidt WE
    Regul Pept; 2001 Sep; 101(1-3):25-33. PubMed ID: 11495676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
    Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
    Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.
    Dong M; Liu G; Pinon DI; Miller LJ
    Biochemistry; 2005 May; 44(17):6693-700. PubMed ID: 15850403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-induced internalization of cholecystokinin receptors. Demonstration of the importance of the carboxyl terminus for ligand-induced internalization of the rat cholecystokinin type B receptor but not the type A receptor.
    Pohl M; Silvente-Poirot S; Pisegna JR; Tarasova NI; Wank SA
    J Biol Chem; 1997 Jul; 272(29):18179-84. PubMed ID: 9218453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
    Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor.
    Schmitz F; Pratt DS; Wu MJ; Kolakowski LF; Beinborn M; Kopin AS
    Mol Pharmacol; 1996 Aug; 50(2):436-41. PubMed ID: 8700154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation process.
    Escrieut C; Gigoux V; Archer E; Verrier S; Maigret B; Behrendt R; Moroder L; Bignon E; Silvente-Poirot S; Pradayrol L; Fourmy D
    J Biol Chem; 2002 Mar; 277(9):7546-55. PubMed ID: 11724786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
    Smeets RL; Fouraux MA; Pouwels W; van Emst-de Vries SE; Ronken E; De Pont JJ; Willems PH
    Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
    Knapp RJ; Vaughn LK; Fang SN; Bogert CL; Yamamura MS; Hruby VJ; Yamamura HI
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1278-86. PubMed ID: 2262906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding sites and transduction process of the cholecystokininB receptor: involvement of highly conserved aromatic residues of the transmembrane domains evidenced by site-directed mutagenesis.
    Jagerschmidt A; Guillaume N; Roques BP; Noble F
    Mol Pharmacol; 1998 May; 53(5):878-85. PubMed ID: 9584214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state.
    Gigoux V; Escrieut C; Silvente-Poirot S; Maigret B; Gouilleux L; Fehrentz JA; Gully D; Moroder L; Vaysse N; Fourmy D
    J Biol Chem; 1998 Jun; 273(23):14380-6. PubMed ID: 9603948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.